n.ramos

TL2 Moderator · Bologna

Contributes reviews on supplier material. Based in Bologna.

Joined 30 December 2024 · last posted 6d

93 posts, newest first. Showing up to 150.

Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #55 · Compounds › Secretagogues & GH axis · 22 Jul 2026 · 5 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
Journal club: what we got wrong in an earlier session Replied, post #90 · Evidence › Journal club · 16 Jul 2026 · 21 likes Coming back to post #88, because the follow-up matters more than the original answer. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes.…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #100 · Sourcing › Vendor reports · 12 Jul 2026 · 2 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
An 18-month record including the parts that went badly Replied, post #66 · Outcomes › Progress reports · 11 Jul 2026 · 26 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
About the Impurities & related substances category Replied, post #9 · Analytics › Impurities & related substances · 4 Jul 2026 · 7 likes This follows post #6 rather than contradicting it. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage,…
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 6 likes post #17 is right about the mechanism and I think understates the practical bit. Cagrilintide alone is discussed less than in combination because the published data is…
Revisiting: How this community labels and discusses unrefereed work Replied, post #6 · Evidence › Preprints · 22 Jun 2026 · 23 likes post #5 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
Naming conventions for research peptides and the confusion they cause Replied, post #16 · Compounds › Other compounds · 16 Jun 2026 · 7 likes This follows post #13 rather than contradicting it. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on…
Second pass at: Metformin co-administration and additive GI effects Replied, post #124 · Practice › Interactions · 12 Jun 2026 · 12 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #47 · Analytics › Method validation · 8 Jun 2026 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #41 · Sourcing › Red flags · 4 Jun 2026 · 7 likes Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and cannot get a clear answer, that is a red flag. Traceability is not…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #44 · Compounds › Semaglutide · 30 May 2026 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #26 · Pharmacology › Formulation chemistry · 26 May 2026 · 1 like Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised formulations protect the peptide during drying and storage. They are not impurities;…
Constipation management, with a dietitian's contribution Replied, post #69 · Practice › Side effects · 23 May 2026 · 3 likes Picking up post #66: that is the part I would want checked first. Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume,…
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #22 · Evidence › Trials · 11 May 2026 · 0 likes Coming back to post #20, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #16 · Analytics › Home & field testing · 7 May 2026 · 18 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
[2026 update] Thyroid function tests during substantial weight change Replied, post #59 · Clinical › Bloodwork · 6 May 2026 · 12 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
Blind submission and why it changes minds — the long version Replied, post #52 · Sourcing › Independent verification · 2 May 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #89 · Analytics › Mass spectrometry · 17 Apr 2026 · 1 like Picking up post #86: that is the part I would want checked first. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+,…
Coming back to: Time to steady state after a dose increase Replied, post #34 · Pharmacology › Pharmacokinetics · 17 Apr 2026 · 10 likes Worth separating two things that post #30 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
Grapefruit: why this class is not the class that cares Replied, post #124 · Practice › Interactions · 5 Apr 2026 · 26 likes Worth separating two things that post #120 runs together. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
Second pass at: Submitting a sample: the process end to end Replied, post #17 · Sourcing › Independent verification · 30 Mar 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #56 · Start Here › Welcome · 21 Mar 2026 · 23 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #45 · Research Methods › Statistics · 4 Mar 2026 · 5 likes Picking up post #42: that is the part I would want checked first. Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one…
Interpreting a result that disagrees with the supplier's certificate Replied, post #146 · Sourcing › Independent verification · 3 Mar 2026 · 0 likes Worth separating two things that post #142 runs together. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are…
[2026 update] Confounding by indication, explained with a concrete example Replied, post #96 · Evidence › Study critique · 28 Feb 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Storing lyophilised material long term: what governs the shelf life Replied, post #81 · Practice › Storage & stability · 25 Feb 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #129 · Analytics › COA interpretation · 10 Feb 2026 · 7 likes Picking up post #126: that is the part I would want checked first. When a document puts the specification in the result column, it has told you the release criterion,…
Dead volume across syringe and needle combinations Replied, post #62 · Devices › Syringes & needles · 28 Jan 2026 · 8 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Adolescents: a distinct evidence base — one year on Replied, post #57 · Clinical › Special populations · 24 Jan 2026 · 19 likes Worth separating two things that post #53 runs together. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent obesity but…
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #6 · Compounds › Repair & healing peptides · 21 Jan 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #9 · Practice › Administration · 15 Jan 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What to include when your question involves a chromatogram Replied, post #13 · Start Here › How to Ask · 1 Jan 2026 · 12 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #6 · Pharmacology › Pharmacokinetics · 1 Jan 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Journal club: PIONEER 6 as a safety trial Replied, post #12 · Evidence › Journal club · 26 Dec 2025 · 24 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
How to read a phase 2 result without treating it as a phase 3 result Replied, post #34 · Compounds › Retatrutide · 26 Dec 2025 · 5 likes I read post #32 twice before replying, because I had assumed the opposite. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #23 · Practice › Side effects · 9 Dec 2025 · 1 like On post #19 — agreed on the reasoning, with one qualification. Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #60 · Compounds › Semaglutide · 2 Dec 2025 · 4 likes I read post #58 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Reading an interaction checker output critically Replied, post #41 · Practice › Interactions · 12 Nov 2025 · 5 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #76 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes post #75 is right about the mechanism and I think understates the practical bit. SURMOUNT-OSA is notable because it used an objective physiological endpoint, the…
What a confidence interval means, from scratch — the long version Replied, post #9 · Research Methods › Statistics · 22 Oct 2025 · 0 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #7 · Compounds › Oral incretins · 16 Oct 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #98 · Lounge › Off topic · 15 Oct 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Pinch or no pinch, and how needle length changes the answer Replied, post #99 · Practice › Administration · 8 Oct 2025 · 0 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #56 · Sourcing › Vendor reports · 14 Sep 2025 · 5 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
Coming back to: What published stability data actually covers, and what it does not Replied, post #140 · Practice › Storage & stability · 14 Sep 2025 · 0 likes This follows post #137 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light…
A preprint whose numbers changed substantially at publication Replied, post #52 · Evidence › Preprints · 14 Sep 2025 · 14 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
When to stop reading forums, including this one Replied, post #21 · Wellbeing › Mental health · 2 Sep 2025 · 14 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
An emergency department visit, described afterwards Replied, post #57 · Safety › Adverse events · 22 Aug 2025 · 5 likes This follows post #54 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #110 · Compounds › Tirzepatide · 21 Aug 2025 · 24 likes I read post #108 twice before replying, because I had assumed the opposite. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others…
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #47 · Compounds › Retatrutide · 13 Aug 2025 · 1 like Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #7 · Evidence › Journal club · 9 Aug 2025 · 6 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
A request that was declined, and the reasoning — a second dataset Replied, post #7 · Documentation › Wiki requests · 5 Aug 2025 · 0 likes Coming back to post #5, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
EU-wide position versus national implementation Replied, post #23 · Regional › European Union · 5 Aug 2025 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Italy: AIFA controls reimbursement through a note system. Weight-management…
When a preprint is the best available evidence and we say so Replied, post #19 · Evidence › Preprints · 3 Aug 2025 · 16 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
"Should I double up?" — answered once, at length, calmly Replied, post #9 · Practice › Administration · 29 Jul 2025 · 16 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
Journal club: SURMOUNT-1, read without the press release Replied, post #156 · Evidence › Journal club · 11 Jul 2025 · 29 likes SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the oral formulation. Note that oral bioavailability is lower…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #48 · Compounds › Cagrilintide & amylin analogues · 11 Jul 2025 · 16 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
Whether an aggregate is worth publishing at all: a disputed topic Replied, post #23 · Data & Tools › Datasets · 3 Jul 2025 · 0 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #121 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 1 like This follows post #118 rather than contradicting it. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #85 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 1 like I read post #83 twice before replying, because I had assumed the opposite. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily…
Comparing my trajectory with the trial curves, carefully Replied, post #11 · Outcomes › Progress reports · 5 Jun 2025 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Protein intake and resistance training: both self-reported and therefore optimistic…
Coming back to: Why quantitation is the hard part, not detection Replied, post #22 · Analytics › Home & field testing · 2 Jun 2025 · 6 likes What physical quantity does the device measure? A colorimetric or lateral-flow method typically responds to a class of chemistry rather than to a specific molecule. It…
Anxiety in the first weeks: drug, situation, or both Replied, post #87 · Wellbeing › Mental health · 12 May 2025 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A certificate with no method stated: what can you conclude? Replied, post #47 · Analytics › COA interpretation · 8 Apr 2025 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #79 · Devices › Cold chain · 4 Apr 2025 · 0 likes Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light exposure. For short-term storage, keeping the vial in its…
Why cagrilintide alone is discussed so much less than in combination Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 19 likes Coming back to post #92, because the follow-up matters more than the original answer. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected…
Why cagrilintide alone is discussed so much less than in combination Replied, post #75 · Compounds › Cagrilintide & amylin analogues · 31 Mar 2025 · 2 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
Preservatives: function, testing, and limits Replied, post #26 · Pharmacology › Formulation chemistry · 31 Mar 2025 · 7 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
Assessing a warm arrival: the decision process Replied, post #17 · Sourcing › Logistics · 22 Mar 2025 · 3 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
Counter-ion form: the field almost nobody reports — one year on Replied, post #87 · Analytics › COA interpretation · 16 Mar 2025 · 23 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Charge states for a 4 kDa peptide, worked through Replied, post #110 · Analytics › Mass spectrometry · 15 Mar 2025 · 24 likes Picking up post #107: that is the part I would want checked first. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because…
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #2 · Evidence › Journal club · 12 Mar 2025 · 2 likes Coming back to the opening post, because the follow-up matters more than the original answer. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with…
Counter-ion form: the field almost nobody reports — one year on Replied, post #62 · Analytics › COA interpretation · 9 Mar 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
UK access routes, dated and sourced Started this topic · Regional › UK & Ireland · 15 Feb 2025 · 52 likes UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because…
Canadian access and provincial variation Replied, post #41 · Regional › North America · 1 Feb 2025 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
What a well-designed human trial of a secretagogue would look like Replied, post #3 · marked as the solution · Compounds › Secretagogues & GH axis · 17 Jan 2025 · 7 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
A page that has drifted out of date and needs a maintainer Replied, post #48 · Documentation › Wiki requests · 6 Jan 2025 · 7 likes Worth separating two things that post #44 runs together. Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion…
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #18 · Practice › Dosing & titration · 19 Dec 2024 · 0 likes On post #14 — agreed on the reasoning, with one qualification. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #12 · Evidence › Journal club · 11 Dec 2024 · 7 likes I read post #10 twice before replying, because I had assumed the opposite. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first…
Transit times by route, from a logged dataset — the long version Replied, post #37 · Sourcing › Logistics · 9 Dec 2024 · 10 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #111 · Practice › Dosing & titration · 24 Nov 2024 · 32 likes Coming back to post #109, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…
When "no data" is the complete and final answer Replied, post #20 · Compounds › Other compounds · 13 Nov 2024 · 14 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #6 · Practice › Reconstitution · 5 Nov 2024 · 17 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #89 · Clinical › Prescriber conversations · 31 Oct 2024 · 30 likes post #88 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Revisiting: Moderation log format change Replied, post #2 · Meta › Announcements · 19 Oct 2024 · 11 likes the opening post answers the question as asked. The question underneath it is different. Archives: older announcements are archived by date. Checking archives is useful…
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #8 · Compounds › Other compounds · 16 Oct 2024 · 27 likes post #7 answers the question as asked. The question underneath it is different. When "no data" is the complete and final answer: if there is no published human data on…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #16 · Clinical › Comorbidities · 10 Oct 2024 · 15 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
Requesting a page: what makes a good request — what changed since Replied, post #30 · Documentation › Wiki requests · 10 Oct 2024 · 27 likes Suggesting content for a page: if you know a maintained page is missing something important, post a suggestion with specific content you think should be added.
Coming back to: Purity assay versus content assay: two different numbers Replied, post #13 · Analytics › COA interpretation · 8 Aug 2024 · 28 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #8 · Analytics › COA interpretation · 18 Jul 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #7 · Compounds › Retatrutide · 15 Jul 2024 · 2 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #5 · Practice › Administration · 7 Jul 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.